Latest Insider Transactions at United Therapeutics Corp (UTHR)
This section provides a real-time view of insider transactions for United Therapeutics Corp (UTHR). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of UNITED THERAPEUTICS Corp to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of UNITED THERAPEUTICS Corp's insiders and make more informed investment decisions.
Insider Transaction List
Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
---|---|---|---|---|---|
Mar 19
2025
|
Christopher Patusky |
SELL
Open market or private sale
|
Direct |
5,000
-21.33%
|
$1,550,000
$310.89 P/Share
|
Mar 19
2025
|
Christopher Patusky |
BUY
Exercise of conversion of derivative security
|
Direct |
5,000
+45.87%
|
$875,000
$175.43 P/Share
|
Mar 10
2025
|
Michael Benkowitz PRESIDENT AND COO |
SELL
Open market or private sale
|
Indirect |
2,000
-43.41%
|
$638,000
$319.92 P/Share
|
Mar 10
2025
|
Michael Benkowitz PRESIDENT AND COO |
BUY
Exercise of conversion of derivative security
|
Indirect |
2,000
+50.0%
|
$222,000
$111.0 P/Share
|
Mar 07
2025
|
Martine A Rothblatt Chairperson & CEO |
BUY
Bona fide gift
|
Indirect |
229,947
+47.11%
|
-
|
Mar 07
2025
|
Martine A Rothblatt Chairperson & CEO |
SELL
Bona fide gift
|
Indirect |
229,947
-93.51%
|
-
|
Mar 06
2025
|
Paul A Mahon EVP & GENERAL COUNSEL |
SELL
Sale (or disposition) back to the issuer
|
Direct |
6,550
-15.12%
|
$2,010,850
$307.68 P/Share
|
Mar 06
2025
|
Paul A Mahon EVP & GENERAL COUNSEL |
BUY
Exercise of conversion of derivative security
|
Direct |
6,550
+13.13%
|
$1,067,650
$163.3 P/Share
|
Mar 03
2025
|
Michael Benkowitz PRESIDENT AND COO |
SELL
Open market or private sale
|
Indirect |
9,679
-43.51%
|
$3,029,527
$313.56 P/Share
|
Mar 03
2025
|
Michael Benkowitz PRESIDENT AND COO |
BUY
Exercise of conversion of derivative security
|
Indirect |
9,679
+50.0%
|
$1,074,369
$111.0 P/Share
|
Feb 28
2025
|
Tommy G Thompson |
SELL
Open market or private sale
|
Direct |
2,500
-22.77%
|
$795,000
$318.34 P/Share
|
Feb 28
2025
|
Tommy G Thompson |
BUY
Exercise of conversion of derivative security
|
Direct |
2,500
+18.55%
|
$437,500
$175.43 P/Share
|
Feb 28
2025
|
Ray Kurzweil |
SELL
Open market or private sale
|
Direct |
15,000
-8.45%
|
$4,770,000
$318.79 P/Share
|
Feb 28
2025
|
Ray Kurzweil |
BUY
Exercise of conversion of derivative security
|
Direct |
15,000
+35.65%
|
$2,625,000
$175.43 P/Share
|
Feb 24
2025
|
Michael Benkowitz PRESIDENT AND COO |
SELL
Open market or private sale
|
Indirect |
10,000
-51.92%
|
$3,610,000
$361.25 P/Share
|
Feb 24
2025
|
Michael Benkowitz PRESIDENT AND COO |
BUY
Exercise of conversion of derivative security
|
Indirect |
10,000
+50.0%
|
$1,110,000
$111.0 P/Share
|
Feb 20
2025
|
Paul A Mahon EVP & GENERAL COUNSEL |
SELL
Sale (or disposition) back to the issuer
|
Direct |
7,700
-17.34%
|
$2,825,900
$367.36 P/Share
|
Feb 20
2025
|
Paul A Mahon EVP & GENERAL COUNSEL |
BUY
Exercise of conversion of derivative security
|
Direct |
7,700
+14.78%
|
$1,255,100
$163.3 P/Share
|
Feb 18
2025
|
Michael Benkowitz PRESIDENT AND COO |
SELL
Open market or private sale
|
Indirect |
10,000
-44.69%
|
$3,700,000
$370.73 P/Share
|
Feb 18
2025
|
Michael Benkowitz PRESIDENT AND COO |
BUY
Exercise of conversion of derivative security
|
Indirect |
10,000
+50.0%
|
$1,110,000
$111.0 P/Share
|
Feb 10
2025
|
Michael Benkowitz PRESIDENT AND COO |
SELL
Open market or private sale
|
Indirect |
10,000
-60.89%
|
$3,480,000
$348.51 P/Share
|
Feb 10
2025
|
Michael Benkowitz PRESIDENT AND COO |
BUY
Exercise of conversion of derivative security
|
Indirect |
10,000
+50.0%
|
$1,110,000
$111.0 P/Share
|
Feb 06
2025
|
Paul A Mahon EVP & GENERAL COUNSEL |
SELL
Sale (or disposition) back to the issuer
|
Direct |
7,700
-17.34%
|
$2,718,100
$353.75 P/Share
|
Feb 06
2025
|
Paul A Mahon EVP & GENERAL COUNSEL |
BUY
Exercise of conversion of derivative security
|
Direct |
7,700
+14.78%
|
$1,255,100
$163.3 P/Share
|
Feb 03
2025
|
Michael Benkowitz PRESIDENT AND COO |
SELL
Open market or private sale
|
Indirect |
10,000
-30.4%
|
$3,520,000
$352.59 P/Share
|
Feb 03
2025
|
Michael Benkowitz PRESIDENT AND COO |
BUY
Exercise of conversion of derivative security
|
Indirect |
10,000
+50.0%
|
$1,110,000
$111.0 P/Share
|
Jan 27
2025
|
Michael Benkowitz PRESIDENT AND COO |
SELL
Open market or private sale
|
Indirect |
10,000
-61.55%
|
$3,720,000
$372.03 P/Share
|
Jan 27
2025
|
Michael Benkowitz PRESIDENT AND COO |
BUY
Exercise of conversion of derivative security
|
Indirect |
10,000
+50.0%
|
$1,110,000
$111.0 P/Share
|
Jan 21
2025
|
Michael Benkowitz PRESIDENT AND COO |
SELL
Open market or private sale
|
Indirect |
10,000
-52.82%
|
$3,650,000
$365.7 P/Share
|
Jan 21
2025
|
Michael Benkowitz PRESIDENT AND COO |
BUY
Exercise of conversion of derivative security
|
Indirect |
10,000
+50.0%
|
$1,110,000
$111.0 P/Share
|
Jan 16
2025
|
Paul A Mahon EVP & GENERAL COUNSEL |
SELL
Sale (or disposition) back to the issuer
|
Direct |
7,700
-17.34%
|
$2,818,200
$366.39 P/Share
|
Jan 16
2025
|
Paul A Mahon EVP & GENERAL COUNSEL |
BUY
Exercise of conversion of derivative security
|
Direct |
7,700
+14.78%
|
$1,255,100
$163.3 P/Share
|
Jan 13
2025
|
Michael Benkowitz PRESIDENT AND COO |
SELL
Open market or private sale
|
Indirect |
10,000
-44.11%
|
$3,640,000
$364.76 P/Share
|
Jan 13
2025
|
Michael Benkowitz PRESIDENT AND COO |
BUY
Exercise of conversion of derivative security
|
Indirect |
10,000
+50.0%
|
$1,110,000
$111.0 P/Share
|
Jan 10
2025
|
Christopher Patusky |
SELL
Open market or private sale
|
Direct |
5,000
-24.31%
|
$1,805,000
$361.39 P/Share
|
Jan 10
2025
|
Christopher Patusky |
BUY
Exercise of conversion of derivative security
|
Direct |
5,000
+45.87%
|
$875,000
$175.43 P/Share
|
Jan 06
2025
|
Michael Benkowitz PRESIDENT AND COO |
SELL
Open market or private sale
|
Indirect |
10,000
-54.37%
|
$3,560,000
$356.02 P/Share
|
Jan 06
2025
|
Michael Benkowitz PRESIDENT AND COO |
BUY
Exercise of conversion of derivative security
|
Indirect |
10,000
+50.0%
|
$1,110,000
$111.0 P/Share
|
Jan 02
2025
|
Paul A Mahon EVP & GENERAL COUNSEL |
SELL
Sale (or disposition) back to the issuer
|
Direct |
7,700
-17.34%
|
$2,772,000
$360.22 P/Share
|
Jan 02
2025
|
Paul A Mahon EVP & GENERAL COUNSEL |
BUY
Exercise of conversion of derivative security
|
Direct |
7,700
+14.78%
|
$1,255,100
$163.3 P/Share
|
Dec 30
2024
|
Nilda Mesa |
SELL
Open market or private sale
|
Direct |
255
-4.41%
|
$90,525
$355.77 P/Share
|
Dec 30
2024
|
Michael Benkowitz PRESIDENT AND COO |
SELL
Open market or private sale
|
Indirect |
10,000
-63.3%
|
$3,560,000
$356.88 P/Share
|
Dec 30
2024
|
Michael Benkowitz PRESIDENT AND COO |
BUY
Exercise of conversion of derivative security
|
Indirect |
10,000
+50.0%
|
$1,110,000
$111.0 P/Share
|
Dec 23
2024
|
Michael Benkowitz PRESIDENT AND COO |
SELL
Open market or private sale
|
Indirect |
10,000
-41.21%
|
$3,610,000
$361.13 P/Share
|
Dec 23
2024
|
Michael Benkowitz PRESIDENT AND COO |
BUY
Exercise of conversion of derivative security
|
Indirect |
10,000
+50.0%
|
$1,110,000
$111.0 P/Share
|
Dec 19
2024
|
Paul A Mahon EVP & GENERAL COUNSEL |
SELL
Sale (or disposition) back to the issuer
|
Direct |
7,700
-17.34%
|
$2,772,000
$360.16 P/Share
|
Dec 19
2024
|
Paul A Mahon EVP & GENERAL COUNSEL |
BUY
Exercise of conversion of derivative security
|
Direct |
7,700
+14.78%
|
$1,255,100
$163.3 P/Share
|
Dec 19
2024
|
Louis W Sullivan |
SELL
Bona fide gift
|
Direct |
1,851
-36.65%
|
-
|
Dec 18
2024
|
Louis W Sullivan |
SELL
Open market or private sale
|
Direct |
26,209
-7.09%
|
$9,802,166
$374.38 P/Share
|
Dec 18
2024
|
Louis W Sullivan |
BUY
Exercise of conversion of derivative security
|
Direct |
15,000
+32.43%
|
$2,625,000
$175.43 P/Share
|